L-ArginineNO Pathway Is Altered in Children with Haemolytic-Uraemic Syndrome (HUS)‎

Abstract EN

The haemolytic uraemic syndrome (HUS) is the most frequent cause of acute renal failure in childhood.

We investigated L-arginine/NO pathway in 12 children with typical HUS and 12 age-matched healthy control subjects.

Nitrite and nitrate, the major NO metabolites in plasma and urine, asymmetric dimethylarginine (ADMA) in plasma and urine, and dimethylamine (DMA) in urine were determined by GC-MS and GC-MS/MS techniques.

Urinary measurements were corrected for creatinine excretion.

Plasma nitrate was significantly higher in HUS patients compared to healthy controls P = 0.021 , whereas urine nitrate was borderline lower in HUS patients compared to healthy controls P = 0.24 .

ADMA plasma concentrations were insignificantly lower, but urine ADMA levels were significantly lower in the HUS patients P = 0.019 .

Urinary DMA was not significantly elevated.

In HUS patients, nitrate R = 0.91 but not nitrite, L-arginine, or ADMA concentrations in plasma correlated with free haemoglobin concentration.

Our results suggest that both NO production and ADMA synthesis are decreased in children with typical HUS.

We hypothesize that in the circulation of children with HUS a vicious circle between the L-arginine/NO pathway and free haemoglobin-mediated oxidative stress exists.

Disruption of this vicious circle by drugs that release NO and/or sulphydryl groups-containing drugs may offer new therapeutic options in HUS.